Related references
Note: Only part of the references are listed.Therapeutic strategies to overcome cisplatin resistance in ovarian cancer
Mengdi Song et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
CCT4 knockdown enhances the sensitivity of cisplatin by inhibiting glycolysis in human esophageal squamous cell carcinomas
Jiarui Fang et al.
MOLECULAR CARCINOGENESIS (2022)
PDK4 promotes tumorigenesis and cisplatin resistance in lung adenocarcinoma via transcriptional regulation of EPAS1
Shuo Yu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Cetuximab promotes RSL3-induced ferroptosis by suppressing the Nrf2/HO-1 signalling pathway in KRAS mutant colorectal cancer
Jiawen Yang et al.
CELL DEATH & DISEASE (2021)
miRNA interplay: mechanisms and consequences in cancer
Meredith Hill et al.
DISEASE MODELS & MECHANISMS (2021)
The Metabolic Fates of Pyruvate in Normal and Neoplastic Cells
Edward V. Prochownik et al.
CELLS (2021)
MicroRNA-375: potential cancer suppressor and therapeutic drug
Jiahui Wei et al.
BIOSCIENCE REPORTS (2021)
Long non-coding RNA SLC2A1-AS1 induced by GLI3 promotes aerobic glycolysis and progression in esophageal squamous cell carcinoma by sponging miR-378a-3p to enhance Glut1 expression
Hongtao Liu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Understanding and overcoming resistance to PARP inhibitors in cancer therapy
Mariana Paes Dias et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
DHA exhibits synergistic therapeutic efficacy with cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via modulation of iron metabolism
Jing Du et al.
CELL DEATH & DISEASE (2021)
MicroRNA-375: potential cancer suppressor and therapeutic drug
Jiahui Wei et al.
BIOSCIENCE REPORTS (2021)
miR-128-3p contributes to mitochondrial dysfunction and induces apoptosis in glioma cells via targeting pyruvate dehydrogenase kinase 1
Changda Qu et al.
IUBMB LIFE (2020)
PDK1 promotes ovarian cancer metastasis by modulating tumor-mesothelial adhesion, invasion, and angiogenesis via α5β1 integrin and JNK/IL-8 signaling
Michelle K. Y. Siu et al.
ONCOGENESIS (2020)
Prediction of miRNA targets by learning from interaction sequences
Xueming Zheng et al.
PLOS ONE (2020)
Metabolic reprogramming and cancer progression
Brandon Faubert et al.
SCIENCE (2020)
The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression
Peter Vaupel et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2019)
MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer
Lu Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Inhibition of Sphingosine Phosphate Receptor 1 Signaling Enhances the Efficacy of VEGF Receptor Inhibition
Anthony S. Fischl et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Histone deacetylases inhibitor MS-275 suppresses human esophageal squamous cell carcinoma cell growth and progression via the PI3K/Akt/mTOR pathway
Shanshan Ma et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Inhibition of glycolysis disrupts cellular antioxidant defense and sensitizes HepG2 cells to doxorubicin treatment
Agnieszka Korga et al.
FEBS OPEN BIO (2019)
Cisplatin: The first metal based anticancer drug
Sumit Ghosh
BIOORGANIC CHEMISTRY (2019)
Metabolic Flexibility in Cancer: Targeting the Pyruvate Dehydrogenase Kinase:Pyruvate Dehydrogenase Axis
Benjamin L. Woolbright et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Baicalin relieves hypoxia-aroused H9c2 cell apoptosis by activating Nrf2/HO-1-mediated HIF1α/BNIP3 pathway (Publication with Expression of Concern. See vol. 49, pg. 676, 2021)
Hailiang Yu et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2019)
Icariin modulates carrageenan-induced acute inflammation through HO-1/Nrf2 and NF-kB signaling pathways
Nagla A. El-Shitany et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
PDK2 induces cisplatin-resistance in lung adenocarcinoma via transcriptional regulation of CNNM3
Tinghua Hu et al.
JOURNAL OF DRUG TARGETING (2019)
Cisplatin and beyond: molecular mechanisms of action and drug resistance development in cancer chemotherapy
Tomaz Makovec
RADIOLOGY AND ONCOLOGY (2019)
Dichloroacetate Overcomes Oxaliplatin Chemoresistance in Colorectal Cancer through the miR-543/PTEN/Akt/mTOR Pathway
Yu Liang et al.
JOURNAL OF CANCER (2019)
Exosomal miR-9 inhibits angiogenesis by targeting MDK and regulating PDK/AKT pathway in nasopharyngeal carcinoma
Juan Lu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Dichloroacetate enhances the antitumor efficacy of chemotherapeutic agents via inhibiting autophagy in non-small-cell lung cancer
Xiao Lu et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Protein S-glutathionylation alters superoxide/hydrogen peroxide emission from pyruvate dehydrogenase complex
Marisa O'Brien et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
Therapeutic Targeting of the Pyruvate Dehydrogenase Complex/Pyruvate Dehydrogenase Kinase (PDC/PDK) Axis in Cancer
Peter W. Stacpoole
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Therapeutic applications of dichloroacetate and the role of glutathione transferase zeta-1
Margaret O. James et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Therapeutic Targeting of the Pyruvate Dehydrogenase Complex/Pyruvate Dehydrogenase Kinase (PDC/PDK) Axis in Cancer
Peter W. Stacpoole
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Incidence trends in oesophageal cancer by histological type: An updated analysis in Sweden
Shao-Hua Xie et al.
CANCER EPIDEMIOLOGY (2017)
Oncogenic role of PDK4 in human colon cancer cells
D. Leclerc et al.
BRITISH JOURNAL OF CANCER (2017)
Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism
Agnieszka Loboda et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
Overexpression of pyruvate dehydrogenase kinase supports dichloroacetate as a candidate for cutaneous melanoma therapy
Helena Populo et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries
Maria Jose Domper Arnal et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Overexpression of Pyruvate Dehydrogenase Kinase 3 Increases Drug Resistance and Early Recurrence in Colon Cancer
Chun-Wun Lu et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)